CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event New debt or obligation
- 4 Open-market sale Director sold 300 shares at $11.11 ($3,334)
- 4 Open-market buy Chief Executive Officer bought 260,869 shares at $5.75 ($1,499,997)
- 4 Option exercise Director acquired 250 shares (option exercise)
- D/A Other Amended Notice of Exempt Offering of Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- 4 Open-market buy Director bought 5,000 shares at $9.68 ($48,383)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K/A Event Executive or director change
- 4 Open-market sale Director sold 300 shares at $9.97 ($2,991)
Page 15 of 28 · 542 filings